Evaxion Biotech AS (EVAX)

Evaxion Biotech AS (EVAX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $36.5M; returns 1 day +1.3%, 1 week +32.9%, 1 year -33.0%.

Evaxion Biotech AS is a clinical-stage TechBio company based in Denmark, specializing in the discovery and development of novel immunotherapies and vaccines using its proprietary AI-Immunology™ platform.

Groups EVAX belongs to

• Clinical Stage Biotech
• AI in Healthcare
• Biotechnology
• Artificial Intelligence
• Immunotherapy
• Healthcare Technology
• Oncology
• Drug Discovery
• Infectious Diseases
• Clinical Stage

EVAX financial model: income statement, cash flow and balance sheet